Literature DB >> 18622475

[Early pancreatic cancer: can the methods currently available identify this disease?].

José Celso Ardengh1, Nelson Coelho, Alessandro Bersch Osvaldt.   

Abstract

OBJECTIVES: Call attention of the gastroenterologists and surgeons on the patients with high risk of developing pancreatic carcinoma, and whether or not forms of surveillance and prevention of this disease, which can be applied to daily clinical practice. DATA SURVEY: It was used the database of PubMed (US National Library of Medicine), looked up the publications of recent years for the groups at risk, molecular biological testing and methods of image used in the identification of small tumors of the pancreas.
BACKGROUND: The survival rates of adenocarcinoma of the pancreas remain negligible, even after the significant advances in diagnosis by imaging, treatment and understanding of the molecular biology of this disease. Although embryonic strategies for surveillance and prevention for people with high risk of pancreatic cancer has developed.
CONCLUSIONS: This review summarizes how to identify people at high risk of developing this disease and what is the state of the art of genetic counseling and screening through techniques of image available.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18622475     DOI: 10.1590/s0004-28032008000200016

Source DB:  PubMed          Journal:  Arq Gastroenterol        ISSN: 0004-2803


  1 in total

1.  THE ROLE OF IMMUNOINFLAMMATORY MARKERS IN THE PROGNOSIS AND RESECTABILITY OF PANCREATIC ADENOCARCINOMA.

Authors:  Tatiana Falcão Eyff; Henrique Rasia Bosi; Mariana Sandrin Toni; Mariana Blanck Zilio; Carlos Otavio Corso; Vivian Pierri Bersch; Alessandro Bersch Osvaldt
Journal:  Arq Bras Cir Dig       Date:  2018-07-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.